Bio Techne (Brazil) Performance

T1CH34 Stock   11.99  0.40  3.23%   
Bio Techne has a performance score of 2 on a scale of 0 to 100. The firm shows a Beta (market volatility) of -0.26, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Bio Techne are expected to decrease at a much lower rate. During the bear market, Bio Techne is likely to outperform the market. Bio Techne right now shows a risk of 2.93%. Please confirm Bio Techne total risk alpha, treynor ratio, value at risk, as well as the relationship between the sortino ratio and maximum drawdown , to decide if Bio Techne will be following its price patterns.

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Bio Techne are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong fundamental indicators, Bio Techne is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
Begin Period Cash Flow199.1 M
Total Cashflows From Investing Activities-96.9 M
  

Bio Techne Relative Risk vs. Return Landscape

If you would invest  1,163  in Bio Techne on October 31, 2025 and sell it today you would earn a total of  36.00  from holding Bio Techne or generate 3.1% return on investment over 90 days. Bio Techne is generating 0.0927% of daily returns and assumes 2.9299% volatility on return distribution over the 90 days horizon. Simply put, 26% of stocks are less volatile than Bio, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days trading horizon Bio Techne is expected to generate 3.88 times more return on investment than the market. However, the company is 3.88 times more volatile than its market benchmark. It trades about 0.03 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.07 per unit of risk.

Bio Techne Target Price Odds to finish over Current Price

The tendency of Bio Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 11.99 90 days 11.99 
about 12.43
Based on a normal probability distribution, the odds of Bio Techne to move above the current price in 90 days from now is about 12.43 (This Bio Techne probability density function shows the probability of Bio Stock to fall within a particular range of prices over 90 days) .
Assuming the 90 days trading horizon Bio Techne has a beta of -0.26. This usually implies as returns on the benchmark increase, returns on holding Bio Techne are expected to decrease at a much lower rate. During a bear market, however, Bio Techne is likely to outperform the market. Additionally Bio Techne has an alpha of 0.1097, implying that it can generate a 0.11 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Bio Techne Price Density   
       Price  

Predictive Modules for Bio Techne

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Bio Techne. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
9.0611.9914.92
Details
Intrinsic
Valuation
LowRealHigh
6.889.8112.74
Details
Naive
Forecast
LowNextHigh
8.3711.3014.23
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
9.9511.4713.00
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Bio Techne. Your research has to be compared to or analyzed against Bio Techne's peers to derive any actionable benefits. When done correctly, Bio Techne's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Bio Techne.

Bio Techne Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Bio Techne is not an exception. The market had few large corrections towards the Bio Techne's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Bio Techne, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Bio Techne within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.11
β
Beta against Dow Jones-0.26
σ
Overall volatility
0.65
Ir
Information ratio 0.01

Bio Techne Fundamentals Growth

Bio Stock prices reflect investors' perceptions of the future prospects and financial health of Bio Techne, and Bio Techne fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Bio Stock performance.

About Bio Techne Performance

By analyzing Bio Techne's fundamental ratios, stakeholders can gain valuable insights into Bio Techne's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Bio Techne has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Bio Techne has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.

Things to note about Bio Techne performance evaluation

Checking the ongoing alerts about Bio Techne for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Bio Techne help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Evaluating Bio Techne's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Bio Techne's stock performance include:
  • Analyzing Bio Techne's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Bio Techne's stock is overvalued or undervalued compared to its peers.
  • Examining Bio Techne's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Bio Techne's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Bio Techne's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Bio Techne's stock. These opinions can provide insight into Bio Techne's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Bio Techne's stock performance is not an exact science, and many factors can impact Bio Techne's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Bio Stock analysis

When running Bio Techne's price analysis, check to measure Bio Techne's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio Techne is operating at the current time. Most of Bio Techne's value examination focuses on studying past and present price action to predict the probability of Bio Techne's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bio Techne's price. Additionally, you may evaluate how the addition of Bio Techne to your portfolios can decrease your overall portfolio volatility.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities